AU2001235896A1 - Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) - Google Patents
Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)Info
- Publication number
- AU2001235896A1 AU2001235896A1 AU2001235896A AU3589601A AU2001235896A1 AU 2001235896 A1 AU2001235896 A1 AU 2001235896A1 AU 2001235896 A AU2001235896 A AU 2001235896A AU 3589601 A AU3589601 A AU 3589601A AU 2001235896 A1 AU2001235896 A1 AU 2001235896A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- tissue
- prodrug
- recited
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20043200P | 2000-04-28 | 2000-04-28 | |
| US60200432 | 2000-04-28 | ||
| PCT/IB2001/000277 WO2001083470A1 (en) | 2000-04-28 | 2001-02-28 | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001235896A1 true AU2001235896A1 (en) | 2001-11-12 |
Family
ID=22741697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001235896A Abandoned AU2001235896A1 (en) | 2000-04-28 | 2001-02-28 | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP1276737A1 (ko) |
| JP (1) | JP2003531900A (ko) |
| KR (1) | KR20020093079A (ko) |
| CN (1) | CN1225466C (ko) |
| AP (1) | AP2002002651A0 (ko) |
| AR (1) | AR028375A1 (ko) |
| AU (1) | AU2001235896A1 (ko) |
| BG (1) | BG107139A (ko) |
| BR (1) | BR0110268A (ko) |
| CA (1) | CA2407535A1 (ko) |
| CO (1) | CO5221125A1 (ko) |
| CR (1) | CR6797A (ko) |
| CZ (1) | CZ20023408A3 (ko) |
| DZ (1) | DZ3310A1 (ko) |
| EA (1) | EA004882B1 (ko) |
| EE (1) | EE200200615A (ko) |
| GT (1) | GT200100064A (ko) |
| HN (1) | HN2001000042A (ko) |
| HR (1) | HRP20020851A2 (ko) |
| HU (1) | HUP0300651A2 (ko) |
| IL (1) | IL152075A0 (ko) |
| IS (2) | IS6567A (ko) |
| MA (1) | MA26897A1 (ko) |
| MX (1) | MXPA02010600A (ko) |
| MY (1) | MY133842A (ko) |
| NO (1) | NO20025132L (ko) |
| NZ (1) | NZ521348A (ko) |
| OA (1) | OA12256A (ko) |
| PA (1) | PA8513301A1 (ko) |
| PE (1) | PE20011270A1 (ko) |
| PL (1) | PL357765A1 (ko) |
| SK (1) | SK14872002A3 (ko) |
| SV (1) | SV2002000418A (ko) |
| TN (1) | TNSN01065A1 (ko) |
| TR (1) | TR200202439T2 (ko) |
| UA (1) | UA73348C2 (ko) |
| UY (1) | UY26680A1 (ko) |
| WO (1) | WO2001083470A1 (ko) |
| YU (1) | YU79602A (ko) |
| ZA (1) | ZA200208605B (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03006872A (es) * | 2001-01-31 | 2003-11-13 | Pfizer Prod Inc | Etanolatos del inhibidor del intercambiador de sodio-hidrogeno de tipo 1. |
| CA2469305A1 (en) * | 2001-12-19 | 2003-06-26 | Frank Robert Busch | Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| EP1499317A1 (en) * | 2002-05-02 | 2005-01-26 | Pfizer Products Inc. | Treatment of diabetes and diabetic complications with nhe-1 inhibitors |
| FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
| ES2220185B1 (es) * | 2002-07-16 | 2006-04-01 | Consejo Sup. De Investig. Cientificas | Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones. |
| US7550480B2 (en) * | 2003-02-14 | 2009-06-23 | Smithkline Beecham Corporation | Compounds |
| RU2518741C1 (ru) * | 2013-03-22 | 2014-06-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1056729B1 (en) * | 1998-02-27 | 2004-12-29 | Pfizer Products Inc. | N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
-
2001
- 2001-02-28 DZ DZ013310A patent/DZ3310A1/fr active
- 2001-02-28 EP EP01908037A patent/EP1276737A1/en not_active Withdrawn
- 2001-02-28 UA UA2002108497A patent/UA73348C2/uk unknown
- 2001-02-28 TR TR2002/02439T patent/TR200202439T2/xx unknown
- 2001-02-28 NZ NZ521348A patent/NZ521348A/en unknown
- 2001-02-28 YU YUP-796/02A patent/YU79602A/sh unknown
- 2001-02-28 BR BR0110268-0A patent/BR0110268A/pt not_active IP Right Cessation
- 2001-02-28 WO PCT/IB2001/000277 patent/WO2001083470A1/en not_active Application Discontinuation
- 2001-02-28 PL PL01357765A patent/PL357765A1/xx not_active Application Discontinuation
- 2001-02-28 EA EA200201023A patent/EA004882B1/ru not_active IP Right Cessation
- 2001-02-28 HU HU0300651A patent/HUP0300651A2/hu unknown
- 2001-02-28 KR KR1020027014355A patent/KR20020093079A/ko active IP Right Grant
- 2001-02-28 OA OA1200200331A patent/OA12256A/en unknown
- 2001-02-28 CZ CZ20023408A patent/CZ20023408A3/cs unknown
- 2001-02-28 MX MXPA02010600A patent/MXPA02010600A/es active IP Right Grant
- 2001-02-28 EE EEP200200615A patent/EE200200615A/xx unknown
- 2001-02-28 SK SK1487-2002A patent/SK14872002A3/sk unknown
- 2001-02-28 JP JP2001580898A patent/JP2003531900A/ja active Pending
- 2001-02-28 IL IL15207501A patent/IL152075A0/xx unknown
- 2001-02-28 AU AU2001235896A patent/AU2001235896A1/en not_active Abandoned
- 2001-02-28 CN CNB018087256A patent/CN1225466C/zh not_active Expired - Fee Related
- 2001-02-28 AP APAP/P/2002/002651A patent/AP2002002651A0/en unknown
- 2001-02-28 CA CA002407535A patent/CA2407535A1/en not_active Abandoned
- 2001-03-06 HN HN2001000042A patent/HN2001000042A/es unknown
- 2001-03-12 PA PA20018513301A patent/PA8513301A1/es unknown
- 2001-04-20 GT GT200100064A patent/GT200100064A/es unknown
- 2001-04-24 UY UY26680A patent/UY26680A1/es not_active Application Discontinuation
- 2001-04-26 AR ARP010101970A patent/AR028375A1/es unknown
- 2001-04-26 MY MYPI20011977A patent/MY133842A/en unknown
- 2001-04-26 PE PE2001000376A patent/PE20011270A1/es not_active Application Discontinuation
- 2001-04-27 SV SV2001000418A patent/SV2002000418A/es not_active Application Discontinuation
- 2001-04-27 CO CO01032977A patent/CO5221125A1/es not_active Application Discontinuation
- 2001-04-27 TN TNTNSN01065A patent/TNSN01065A1/fr unknown
-
2002
- 2002-09-23 BG BG107139A patent/BG107139A/bg unknown
- 2002-09-24 IS IS6567A patent/IS6567A/is unknown
- 2002-10-18 MA MA26875A patent/MA26897A1/fr unknown
- 2002-10-18 CR CR6797A patent/CR6797A/es not_active Application Discontinuation
- 2002-10-21 IS IS6588A patent/IS6588A/is unknown
- 2002-10-24 ZA ZA200208605A patent/ZA200208605B/en unknown
- 2002-10-25 HR HR20020851A patent/HRP20020851A2/hr not_active Application Discontinuation
- 2002-10-25 NO NO20025132A patent/NO20025132L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6492401B1 (en) | N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia | |
| CA2303594C (en) | Compounds for treating and preventing diabetic complications | |
| AU2001235896A1 (en) | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) | |
| US6852733B2 (en) | Sodium-hydrogen exchanger type 1 inhibitor | |
| KR100464526B1 (ko) | 나트륨-수소 교환체 타입 1 억제제 결정 | |
| TWI221152B (en) | Method for preparing sodium-hydrogen exchanger type 1 inhibitor | |
| JPH1087658A (ja) | 新規２，４−ジオキソピロリジンおよび２，４−ジオキソテトラヒドロフラン誘導体及び該化合物を有効成分とする医薬 | |
| AU2005201428A1 (en) | Method for preparing sodium-hydrogen exchanger type 1 inhibitor |